Join Us

We are 218,658 members in 84 forums discussing 161,163 topics.

Help with Abbreviations

Topic: Breaking Research News from Breastcancer.org

Forum: Clinical Trials, Research News, Podcasts, and Study Results —

Share your research articles, interpretations and experiences here. Let us know how these studies affect you and your decisions.

↓ Jump to Bottom

Posted on: Apr 16, 2012 12:33PM - edited Jan 16, 2016 02:28PM by Moderators

Moderators wrote:

Breastcancer.org strives to bring you updates on the latest breast cancer research through its Research News program. Medical experts at Breastcancer.org provide easy-to-understand summaries of what the research means for YOU.

Check out this thread on a regular basis to see all the breaking news about current breast cancer research from our experts.

Get Personalized Research News Stories JUST for You!
Don't forget to fill out your profile: In the top right hand corner of the screen, under My Profile, you'll find My Diagnoses and My Treatments. Once you've provided enough information, we'll send recommended articles. Members can save these articles for later, or archive them when they're finished with them.

If you would like to receive Personalized Research News articles, based on diagnosis and treatment information, you'll need to go into "My Profile" and under the "Recommended Articles", click "turn on".

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Page 38 of 38 (1,118 results)

Posts 1111 - 1118 (1,118 total)

Log in to post a reply

Oct 23, 2020 03:25PM Moderators wrote:

Textured Implants May Be Linked to Breast Cancer Recurrence, Study Suggests
October 20, 2020
A small study found that women who had textured implants for reconstruction after breast cancer surgery had a small but statistically significant increase in the risk of the breast cancer coming back. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 23, 2020 03:26PM - edited Oct 23, 2020 03:33PM by Moderators

Adding Tecentriq to Chemotherapy Before Surgery for Early-Stage Triple-Negative Breast Cancer Improves pCR Rates
October 21, 2020
Adding Tecentriq to chemotherapy before surgery for early-stage triple-negative breast cancer offered higher pathologic complete response rates than chemotherapy alone, no matter the PD-L1 status of the cancer. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 29, 2020 12:49PM Moderators wrote:

Studies Show Conflicting Results With Tecentriq and Chemotherapy for Metastatic Triple-Negative Breast Cancer
October 23, 2020
When treating locally advanced or metastatic triple-negative breast cancer for the first time, adding Tecentriq to Taxol did not improve survival, while adding Tecentriq to Abraxane did improve survival. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 29, 2020 12:50PM Moderators wrote:

Interval Breast Cancers Found Between Regular Screening Mammograms Seem More Aggressive
October 27, 2020
Breast cancers found in between regular screening mammograms — called interval cancers by doctors — were more likely to have aggressive characteristics, and women diagnosed with them were more likely to die from breast cancer compared to breast cancers found by routine screening. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 29, 2020 12:52PM Moderators wrote:

Early Results Suggest Ibrance Plus Faslodex as First Treatment Improves Outcomes for Metastatic Hormone-Receptor-Positive, HER2-Negative Breast Cancer
October 27, 2020
Adding Ibrance to Faslodex as a first treatment for advanced-stage or metastatic hormone-receptor-positive, HER2-negative breast cancer that either came back (recurred) more than 1 year after completing 5 or more years of hormonal therapy or was metastatic at first diagnosis improved progression-free survival compared to Faslodex alone. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Nov 5, 2020 11:20AM Moderators wrote:

Pathologic Complete Response to Targeted Therapy Before Surgery Linked to Better Survival for Early-Stage HER2-Positive Breast Cancer
October 30, 2020
Women diagnosed with early-stage HER2-positive breast cancer treated with Herceptin and Tykerb before surgery who had a pathologic complete response (pCR) had better survival than women who didn't have a pCR. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Nov 5, 2020 11:21AM Moderators wrote:

Can Some Older Women With Early-Stage HER2-Positive Breast Cancer Skip Chemotherapy?
October 30, 2020
Certain woman age 70 to 80 may be able to skip chemotherapy after surgery for early-stage HER2-positive disease and be treated with Herceptin alone. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Nov 17, 2020 02:27PM Moderators wrote:

FDA Approves Immunotherapy Keytruda for PD-L1-Positive Triple-Negative Breast Cancer
November 13, 2020
On Nov. 13, 2020, the FDA approved the immunotherapy Keytruda in combination with chemotherapy to treat unresectable locally advanced or metastatic triple-negative, PD-L1-positive breast cancer. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...

Page 38 of 38 (1,118 results)

↑ Back to top